Humana (HUM) Given Daily Coverage Optimism Score of 2.14

News headlines about Humana (NYSE:HUM) have trended positive this week, according to InfoTrie. The research group identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Humana earned a news sentiment score of 2.14 on their scale. InfoTrie also assigned news headlines about the insurance provider an news buzz score of 10 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company’s share price in the next few days.

Here are some of the news headlines that may have impacted Humana’s analysis:

A number of brokerages recently weighed in on HUM. MED reissued an “outperform” rating and issued a $373.00 price target (up previously from $350.00) on shares of Humana in a report on Thursday. Credit Suisse Group raised their price target on shares of Humana from $370.00 to $390.00 and gave the company an “outperform” rating in a report on Thursday. SunTrust Banks reissued a “hold” rating and issued a $350.00 price target on shares of Humana in a report on Thursday, August 2nd. Cowen began coverage on shares of Humana in a report on Monday, September 17th. They issued a “market perform” rating and a $372.00 price target for the company. Finally, Morgan Stanley set a $418.00 price target on shares of Humana and gave the company a “buy” rating in a report on Thursday. Seven research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $352.30.

HUM traded down $14.39 during trading on Thursday, reaching $339.59. 1,067,167 shares of the company’s stock were exchanged, compared to its average volume of 747,680. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.43 and a current ratio of 1.43. Humana has a fifty-two week low of $231.90 and a fifty-two week high of $355.88. The firm has a market capitalization of $45.71 billion, a PE ratio of 29.00, a P/E/G ratio of 1.65 and a beta of 1.03.

Humana (NYSE:HUM) last released its earnings results on Wednesday, November 7th. The insurance provider reported $4.58 EPS for the quarter, topping analysts’ consensus estimates of $4.29 by $0.29. Humana had a net margin of 2.48% and a return on equity of 17.43%. The firm had revenue of $14.21 billion during the quarter, compared to analyst estimates of $13.97 billion. During the same quarter in the previous year, the business earned $3.39 EPS. Equities analysts forecast that Humana will post 14.18 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 25th. Shareholders of record on Monday, December 31st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.59%. The ex-dividend date is Friday, December 28th. Humana’s dividend payout ratio is presently 17.08%.

In other Humana news, insider Elizabeth D. Bierbower sold 3,092 shares of Humana stock in a transaction on Thursday, August 16th. The shares were sold at an average price of $330.00, for a total transaction of $1,020,360.00. Following the completion of the sale, the insider now owns 14,289 shares of the company’s stock, valued at approximately $4,715,370. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Bruce D. Broussard sold 18,000 shares of Humana stock in a transaction on Monday, September 10th. The stock was sold at an average price of $328.66, for a total transaction of $5,915,880.00. Following the sale, the chief executive officer now directly owns 71,085 shares of the company’s stock, valued at approximately $23,362,796.10. The disclosure for this sale can be found here. 0.60% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY WARNING: This story was originally posted by WKRB News and is the sole property of of WKRB News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of United States and international copyright and trademark legislation. The legal version of this story can be accessed at

Humana Company Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.

Further Reading: The Discount Rate – What You Need to Know

Insider Buying and Selling by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with's FREE daily email newsletter.

Leave a Reply